发明授权
- 专利标题： Combination therapy for the treatment of HCV infection
- 专利标题（中）： 联合治疗HCV感染治疗
-
申请号： US12598802申请日： 2008-05-05
-
公开(公告)号： US08258116B2公开(公告)日： 2012-09-04
- 发明人: Ann Kwong , Nagraj Mani , Yi Zhou , Chao Lin
- 申请人： Ann Kwong , Nagraj Mani , Yi Zhou , Chao Lin
- 申请人地址： US MA Cambridge
- 专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人地址： US MA Cambridge
- 代理机构： Honigman Miller Schwartz and Cohn LLP
- 代理商 Noel E. Day; Jonathan P. O'Brien
- 国际申请： PCT/US2008/005758 WO 20080505
- 国际公布： WO2008/137126 WO 20081113
- 主分类号： A01N43/04
- IPC分类号： A01N43/04 ; A61K31/70
摘要：
The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.
公开/授权文献
- US20100172866A1 Combination Therapy for the Treatment of HCV Infection 公开/授权日：2010-07-08